A higher preconceptional paternal body mass index influences fertilization rate and preimplantation embryo development.
assisted reproductive techniques/ICSI
body mass index
embryonic development
male
obesity
spermatozoa
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
16
10
2021
received:
26
08
2021
accepted:
09
11
2021
pubmed:
16
11
2021
medline:
7
4
2022
entrez:
15
11
2021
Statut:
ppublish
Résumé
Obesity is a worldwide problem affecting the health of millions of people throughout the life course. Studies reveal that obesity impairs sperm parameters and epigenetics, potentially influencing embryonic development. To investigate the association between preconceptional paternal body mass index (BMI) and embryo morphokinetics using a time-lapse incubator and in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcomes. Participants were recruited from a tertiary hospital in this prospective periconceptional cohort study. A total of 211 men were included: 86 with normal weight (BMI < 25.0), 94 overweight (BMI 25-29.9), and 41 obese (BMI ≥ 30). These men were part of a couple that underwent IVF/ICSI treatment with ejaculated sperm after which 757 embryos were cultured in a time-lapse incubator. The main outcome parameters consisted of fertilization rate, embryo developmental morphokinetics, embryo quality assessed by a time-lapse prediction algorithm (KIDScore), and live birth rate. A higher paternal BMI was associated with faster development of the preimplantation embryo, especially during the first cleavage divisions (t2: -0.11 h (p = 0.05) and t3: -0.19 h (p = 0.01)). Embryo quality using the KIDScore was not altered. The linear regression analysis, after adjustment for confounders (paternal age, ethnicity, smoking, alcohol use, education, total motile sperm count, and maternal age and BMI), showed an inverse association between paternal BMI and fertilization rate (effect estimate: -0.01 (p = 0.002)), but not with the live birth rate. Our data demonstrate that a higher preconceptional paternal BMI is associated with a reduced fertilization rate in IVF/ICSI treatment. Our findings underline the importance of a healthy paternal weight during the preconception period.
Sections du résumé
BACKGROUND
Obesity is a worldwide problem affecting the health of millions of people throughout the life course. Studies reveal that obesity impairs sperm parameters and epigenetics, potentially influencing embryonic development.
OBJECTIVE
To investigate the association between preconceptional paternal body mass index (BMI) and embryo morphokinetics using a time-lapse incubator and in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcomes.
MATERIALS AND METHODS
Participants were recruited from a tertiary hospital in this prospective periconceptional cohort study. A total of 211 men were included: 86 with normal weight (BMI < 25.0), 94 overweight (BMI 25-29.9), and 41 obese (BMI ≥ 30). These men were part of a couple that underwent IVF/ICSI treatment with ejaculated sperm after which 757 embryos were cultured in a time-lapse incubator. The main outcome parameters consisted of fertilization rate, embryo developmental morphokinetics, embryo quality assessed by a time-lapse prediction algorithm (KIDScore), and live birth rate.
RESULTS
A higher paternal BMI was associated with faster development of the preimplantation embryo, especially during the first cleavage divisions (t2: -0.11 h (p = 0.05) and t3: -0.19 h (p = 0.01)). Embryo quality using the KIDScore was not altered. The linear regression analysis, after adjustment for confounders (paternal age, ethnicity, smoking, alcohol use, education, total motile sperm count, and maternal age and BMI), showed an inverse association between paternal BMI and fertilization rate (effect estimate: -0.01 (p = 0.002)), but not with the live birth rate.
DISCUSSION AND CONCLUSION
Our data demonstrate that a higher preconceptional paternal BMI is associated with a reduced fertilization rate in IVF/ICSI treatment. Our findings underline the importance of a healthy paternal weight during the preconception period.
Identifiants
pubmed: 34779151
doi: 10.1111/andr.13128
pmc: PMC9299449
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
486-494Informations de copyright
© 2021 American Society of Andrology and European Academy of Andrology.
Références
Hum Reprod. 2015 Jan;30(1):122-32
pubmed: 25391239
J Assist Reprod Genet. 2001 Jul;18(7):382-6
pubmed: 11499322
Hum Reprod. 2012 May;27(5):1391-400
pubmed: 22357767
Reprod Biomed Online. 2018 Apr;36(4):459-471
pubmed: 29452915
Oncotarget. 2017 Jun 27;8(40):67394-67405
pubmed: 28978041
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Hum Reprod. 2014 Dec;29(12):2650-60
pubmed: 25344070
Obes Rev. 2015 Aug;16(8):621-38
pubmed: 26016557
Int J Epidemiol. 2016 Apr;45(2):374-81
pubmed: 26224071
BMC Genomics. 2013 Apr 28;14:288
pubmed: 23622456
Hum Mol Genet. 2014 Jan 1;23(1):12-23
pubmed: 23943794
Hum Reprod Update. 2008 May-Jun;14(3):243-58
pubmed: 18281241
Hum Reprod Update. 2013 May-Jun;19(3):221-31
pubmed: 23242914
Nat Rev Urol. 2010 Mar;7(3):153-61
pubmed: 20157305
Hum Reprod. 2016 Oct;31(10):2231-44
pubmed: 27609980
Cell Metab. 2017 Mar 7;25(3):544-558
pubmed: 28273477
Obstet Gynecol. 2011 Jul;118(1):63-70
pubmed: 21691164
Andrology. 2022 Mar;10(3):486-494
pubmed: 34779151
Hum Reprod. 2013 Mar;28(3):794-800
pubmed: 23293223
Proc Nutr Soc. 2008 Feb;67(1):1-8
pubmed: 18234126
J Biomed Sci. 2016 Mar 29;23:36
pubmed: 27026099
Fertil Steril. 2011 Apr;95(5):1700-4
pubmed: 21145051
Reprod Biomed Online. 2005 Mar;10(3):370-5
pubmed: 15820045
Epigenetics. 2020 Jan - Feb;15(1-2):32-46
pubmed: 31354029
Front Genet. 2019 Apr 18;10:337
pubmed: 31057600
Andrologia. 2015 Apr;47(3):360-4
pubmed: 24717066
Fertil Steril. 2003 Apr;79(4):829-43
pubmed: 12749418
Cell Metab. 2016 Feb 9;23(2):369-78
pubmed: 26669700
J Clin Endocrinol Metab. 2003 Jan;88(1):166-73
pubmed: 12519847
J Obes Metab Syndr. 2020 Mar 30;29(1):18-25
pubmed: 32146733
Cell. 2010 Dec 23;143(7):1084-96
pubmed: 21183072
Mol Nutr Food Res. 2020 May;64(9):e1900696
pubmed: 32032459
Lancet. 2007 Mar 3;369(9563):743-749
pubmed: 17336650
Hum Reprod. 2008 Feb;23(2):324-8
pubmed: 18077317
Sci Rep. 2021 Feb 5;11(1):3216
pubmed: 33547328
Mol Cell Endocrinol. 2010 Jan 15;314(1):110-7
pubmed: 19683557
J Assist Reprod Genet. 2019 Jun;36(6):1109-1116
pubmed: 31062218
Sci Rep. 2016 Jul 14;6:29787
pubmed: 27412918
Basic Clin Androl. 2017 Oct 26;27:20
pubmed: 29123667
Hum Reprod. 2004 Jul;19(7):1644-6
pubmed: 15142995
Clin Epigenetics. 2016 May 06;8:51
pubmed: 27158277
Development. 2016 Feb 15;143(4):635-47
pubmed: 26718009
J Biomed Biotechnol. 2011;2011:368276
pubmed: 21912480
Reprod Biomed Online. 2015 Nov;31(5):593-604
pubmed: 26380863